58809-555-08 : NDC 2026 Code

58809-555-08 : Dextromethorphan Hydrobromide, Guaifenesin, And Phenylephrine Hydrochloride ( Vanacof Dm )

Additionally :

You can get information about “58809-555-08” NDC code in 58809-555-08 in HTML format

HTML | 58809-555-08 in TXT (Plain Text) format

TXT | 58809-555-08 in PDF (Portable Document Format)

PDF | 58809-555-08 in XML format

XML formats.

NDC Code : 58809-555-08 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "58809-555-08",
    "PackageDescription": "240 mL in 1 BOTTLE (58809-555-08) ",
    "NDC11Code": "58809-0555-08",
    "ProductNDC": "58809-555",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Vanacof Dm",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dextromethorphan Hydrobromide, Guaifenesin, And Phenylephrine Hydrochloride",
    "DosageFormName": "LIQUID",
    "RouteName": "ORAL",
    "StartMarketingDate": "20130601",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012",
    "LabelerName": "GM Pharmaceuticals, INC",
    "SubstanceName": "DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE",
    "StrengthNumber": "18; 200; 10",
    "StrengthUnit": "mg/15mL; mg/15mL; mg/15mL",
    "Pharm_Classes": "Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-04",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20130601",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}